The association between social support, intrusive thoughts, avoidance, and adjustment following an experimental cancer treatment

Psycho-Oncology

Volumn 12, Issue 5, 2003, Pages 453-462

  Devine, Danielle ^a   Parker, Patricia A ^a   Fouladi, Rachel T ^a   Cohen, Lorenzo ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE;

ACTIVE IMMUNIZATION; ADJUSTMENT; ADULT; AGED; ARTICLE; AVOIDANCE BEHAVIOR; CANCER IMMUNOTHERAPY; CLINICAL TRIAL; COGNITION; DISEASE ASSOCIATION; DISTRESS SYNDROME; FEMALE; FOLLOW UP; HUMAN; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; MELANOMA; MENTAL HEALTH; METASTASIS; NEPHRECTOMY; PHASE 1 CLINICAL TRIAL; POSTTRAUMATIC COMPLICATION; PREDICTION; QUALITY OF LIFE; SOCIAL ASPECT; SOCIAL SUPPORT; THINKING;

ADAPTATION, PSYCHOLOGICAL; ADULT; AGED; AVOIDANCE LEARNING; CARCINOMA, RENAL CELL; COMBINED MODALITY THERAPY; DEFENSE MECHANISMS; FEAR; FEMALE; HUMANS; IMMUNOTHERAPY, ACTIVE; KIDNEY NEOPLASMS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; NEPHRECTOMY; PERSONALITY INVENTORY; PROGNOSIS; QUALITY OF LIFE; SICK ROLE; SKIN NEOPLASMS; SOCIAL SUPPORT; THINKING;

EID: 0037961090     PISSN: 10579249     EISSN: None     Source Type: Journal    
DOI: 10.1002/pon.656     Document Type: Article

References (50)

1. Aaronson NK, Meyerowitz BE, Bard M et al. 1991. Quality of life research in oncology. Past achievements and future priorities. Cancer 67: 839-843.
2. Aiken LS, West SG. 1991. Multiple Regression: Testing and Interpreting Interactions. Sage: Newbury Park, CA.
3. American Psychiatric Association. 1994. Diagnostic and Statistical Manual of Mental Disorders (4th edn), American Psychiatric Association: Washington, DC.
4. Andrykowski MA, Cordova MJ, Studts JL, Miller TW. 1998. Diagnosis of posttraumatic stress disorder following treatment for breast cancer. J Consult Clin Psychol 66: 586-590.
5. Andrykowski MA, Redd WH, Hatfield AK. 1985. Development of anticipatory nausea: A prospective analysis. J Consult Clin Psychol 53: 447-454.
6. Baron RM, Kenny DA 1986. The moderator-mediator distinction in social psychology research: Conceptual, strategic and statistical considerations. J Pers Soc Psychol 17: 89-106.
7. Bloom JR, Spiegel D. 1984. The relationship of two dimensions of social support to the psychological well-being and social functioning of women with advanced breast cancer. Soc Sci Med 19: 831-837.
8. Chemtob C, Roitblat HL, Hamada RS, Carlson JG, Twentyman CT. 1988. A cognitive action theory of posttraumatic stress disorder. J Anxiety Disorders 2: 253-275.
9. Cohen S, Wills TA. 1985. Stress, social support, and the buffering hypothesis: A critical review. Psychol Bull 98: 310-357.
10. Cohen L, De Moor C, Amato RJ. 2001. The association between treatment-specific optimism and depressive symptomatology in patients enrolled in a phase I cancer clinical trial. Cancer 91: 1949-1955.
11. Cohen S, Mermelstein R, Kamarck T, Hoberman H. 1985. Measuring the functional components of social support. In Theory, Research, and Applications, Sarason IA, Sarason B (Eds). Martinus Nijjhof: The Hague, Holland; 73-94.
12. Cordova MJ, Andrykowski MA, Kenady DE, McGrath PC, Sloan DA, Redd WH. 1995. Frequency and correlates of posttraumatic-stress-disorder-like symptoms after treatment for breast cancer. J Consult Clin Psychol 63: 981-986.
13. Daugherty C, Ratain MJ, Grochowski E et al. 1995. Perceptions of cancer patients and their physicians involved in phase I trials. J Clin Oncol 13: 1062-1072.
14. Decoster G, Stein G, Holdener EE. 1990. Responses and toxic deaths in phase I clinical trials. Ann Oncol 2: 175-181.
15. Derogatis LR. Brief Symptom Inventory: Administration, Scoring and Procedures Manual, (3rd edn). National Computer Systems, Inc.: Minneapolis, MN, 1993.
16. Derogatis LR, Melisaratos N. 1983. The brief symptom inventory: An introductory report. Psychol Med 13: 595-605.
17. Ell K, Nishimoto RH, Mediansky L, Mantell JE, Hamovitch MB. 1992. Social relations, social support and survival among patients with cancer. J Psychosom Res 36: 531-541.
18. Estey E, Hoth D, Simon R, Marsoni S, Leyland-Jones B, Wittes R. 1986. Therapeutic response in phase I trials of antineoplastic agents. Cancer Treat Rep 70: 1105-1115.
19. Foa E, Steketee G, Rothbaum B. 1989. Behavioral/cognitive conceptualizations of post-traumatic stress disorder. Behav Ther 20: 155-176.
20. Green BL, Epstein SA, Krupnick JL, Rowland JH. 1997. Trauma and medical illness: Assessing trauma-related disorders in medical settings. In Victim and Survivor Populations, Wilson JP, Keane TM (eds). The Guilford Press: New York; 160-191.
21. Greer S, Moorey S, Baruch JDR et al. 1992. Adjuvant psychological therapy for patients with cancer: A prospective randomized trial. Br Med J 304: 675-680.
22. Gross JJ, Levenson RW. 1993. Emotional suppression: Physiology, self-report, and expressive behavior. J Pers Soc Psychol 64: 970-986.
23. Gross JJ, Levenson RW. 1997. Hiding feelings: The acute effects of inhibiting negative and positive emotion. J Abnorm Psychol 106: 95-103.
24. Helgeson VS, Cohen S. 1996. Social support and adjustment to cancer: Reconciling descriptive, correlational, and intervention research. Health Psychol 15: 135-148.
25. Horowitz MT, 1986. Stress Response Syndromes. Jason Aronson, New York.
26. Horowitz M, Wilner N, Alvarez W. 1979. Impact of Events Scale: Measure of subjective stress. Psychosom Med 41: 209-218.
27. Jamison KR, Wellisch DK, Pasnau RO. 1978. Psychosocial aspects of mastectomy: I. The woman's perspective. Am J Psychiatry 135: 432-436.
28. Kliewer W, Lepore SJ, Oskin D, Johnson PD. 1998. The role of social and cognitive processes in children's adjustment to community violence. J Consult Clin Psychol 66: 199-209.
29. Koopman C, Hermanson K, Diamond S, Angell K, Splegel D. 1998. Social support, life stress, pain, and emotional adjustment to advanced breast cancer. Pscyho-Oncology 7: 101-111.
30. Lepore SJ, Helgeson VS. 1998. Social constraints, intrusive thoughts, and mental health after prostate cancer. J Soc Clin Psychol 17: 89-106.
31. Lepore SJ, Silver RC, Wortman CB, Wayment HA. 1996. Social constraints, intrusive thoughts, and depressive symptoms among bereaved mothers. J Pers Soc Psychol 70: 271-282.
32. Manne S, Glassman M. 2000. Perceived control, coping efficacy, and avoidance coping as mediators between spouses' unsupportive behaviors and cancer patients' psychological distress. Health Psychol 19: 155-164.
33. Northouse AL. 1988. Social support in patients' and husbands' adjustment to breast cancer. Nurs Res 37: 91-95.
34. Pennebaker JW. Confession, Inhibition, and Disease. Academic Press: Orlando, 1989.
35. Petrie KJ, Booth RJ, Pennebaker JW. 1998. The immunological effects of thought suppression. J Pers Soc Psychol 75: 1264-1272.
36. Ratain MJ, Mick R, Schilsky RL et al. 1993. Statistical and ethical issues in the design and conduct of phase I and II clinical trials of new anticancer agents. J Natl Cancer Inst 85: 1637-1643.
37. Redd WH, Dadds MR, Futterman AD, Taylor KL, Bovbjerg DH. 1994. Nausea induced by mental images of chemotherapy. Cancer 73: 756.
38. Redd WH, Jacobsen PB, Andrykowski MA. 1989. Behavioral side effects of adjuvant chemotherapy. Recent Results Cancer Res 115: 272-278.
39. Redd WH, Silberfarb PM, Andersen BL et al. 1991. Physiologic and psychobehavioral research in oncology. Cancer 67: 813-822.
40. Smith MY, Redd WH, Peyser C, Vogl D. 1999. Post-traumatic stress disorder in cancer: A review. Psycho-Oncology 8: 521-537.
41. Spiegel D. 1997. Psychosocial aspects of breast cancer treatment. Semin Oncol 24: 36-47.
42. Stanton AL, Danoff-Burg S, Cameron CL et al. 2000. Emotionally expressive coping predicts psychological and physical adjustment to breast cancer. J Consult Clin Psychol 68: 875-882.
43. Stewart AL, Greenfield S, Hays RD et al. 1989. Functional status and well-being of patients with chronic conditions. JAMA 262: 907-913.
44. Thewes B, Meiser B, Hickie JB. 2001. Psychometric properties of the impact of event scale amongst women at increased risk for hereditary breast cancer. Psycho-Oncology 10: 459-468.
45. Von Hoff DD TJ. 1991. Response rates, duration of response, and dose response effects in phase I studies of antineoplastics. Invest New Drugs 9: 115-122.
46. Ware JE, Johnston SA, Davies-Avery A et al. 1994a. Conceptualization and Measurement of Health for Adults in the Health Insurance Study (Mental Health R-1987/3-HEW: 3). RAND Corporation: Santa Monica, CA.
47. Ware JE, Kosinski M, Keller SD. 1994b. Physical and Mental Health Summary Scales: A User's Manual. Health Assessment Lab: Boston, MA.
48. Ware JE Jr, Snow KK, Kosinski M, Gandek B. 1993. SF-36 Health Survey Manual and Interpretation Guide. The Health Institute, New England Medical Center Hospitals, Inc.: Boston.
49. Wegner DM, Schneider DJ, Carter SRd, White TL. 1987. Paradoxical effects of thought suppression. J Pers Soc Psychol 53: 5-13.
50. Wilson JP. 1989. Trauma, Transformation, and Healing. Brunner/Mazel: New York.